Groundbreaking Alzheimer's Research in Oklahoma

In Oklahoma, around 76,000 people are living with Alzheimer's disease, a number that has surged by 13% in just five years. Despite the growing need for effective treatments, current therapies have struggled to slow or stop the progression of age-related dementia.

Sreemathi Logan, Ph.D., an assistant professor in the Department of Biochemistry and Physiology at the University of Oklahoma College of Medicine, is leading a groundbreaking effort to understand cognitive decline in aging, thanks to $2.2 million in federal funding. Her research aims to uncover new strategies for identifying and targeting Alzheimer's and other cognitive impairments, potentially leading to life-changing medications.

This research Logan and colleagues at the Oklahoma Center for Geroscience and Healthy Brain Aging is crucial because it could lead to new treatments that help maintain brain health and improve the quality of life for those with Alzheimer's. For the many caregivers in Oklahoma and beyond, these advancements offer hope for better support and more effective care strategies.

Logan's innovative approach could be a game changer in the fight against dementia, benefiting patients and their families. This research represents a potential new treatment for dementia, but also underscores the commitment of OU Health and the University of Oklahoma College of Medicine tripartite mission to advancing patient care through clinical, innovative research, and educational mission.

Read more from the University of Oklahoma about innovative studies transforming dementia care.
OU College of Medicine Researcher Looks to Turn Back the Clock on Dementia